Purification is where most of the cost of a custom peptide sits, and understanding the trade-off between purity and recovery prevents unrealistic specifications.
Key Takeaways
- Crude material is loaded onto a reversed-phase column and eluted with an increasing organic gradient.
- Collecting only the centre of the peak raises purity and lowers recovery; collecting broadly does the opposite.
- Pooled fractions are typically concentrated and lyophilised.
How the separation works
Crude material is loaded onto a reversed-phase column and eluted with an increasing organic gradient. Species separate by hydrophobicity, and the target peak is collected in fractions that are then analysed individually before pooling.
Loading versus resolution
Higher loading improves throughput but broadens peaks and reduces separation from closely related impurities. Difficult separations often require accepting a shallower gradient and more runs rather than forcing more material through at once.
For related mechanism work, see peptide cyclisation methods.
The purity-recovery trade-off
Collecting only the centre of the peak raises purity and lowers recovery; collecting broadly does the opposite. A specification of 98 percent instead of 95 percent can reduce yield substantially, which is why tighter specs cost more.
Fraction analysis before pooling
Analyse every fraction rather than pooling by retention time alone. Co-eluting impurities with slightly different mass are common, and pooling by UV trace alone is how they end up in the final product.
Post-purification handling
Pooled fractions are typically concentrated and lyophilised. The choice of counterion and the residual solvent profile are set at this stage, so salt-form requirements must be specified before purification rather than after.
Experimental Conditions and Practical Setup
Loading is determined by running an analytical separation first and scaling the load to keep the target peak resolved from its nearest neighbour. Fractions are collected across the peak rather than at a fixed time, analysed individually, and pooled only after the chromatograms have been reviewed, because co-eluting impurities are common.
Purity specification versus practical recovery
| Specification | Relative recovery | Cost implication |
|---|---|---|
| Crude, no purification | Highest | Not suitable for most work |
| ≥90% | High | Baseline for screening |
| ≥95% | Moderate | Standard research grade |
| ≥98% | Lower | Narrower centre cut, more material discarded |
Practical Notes for the Bench
- Specify the required salt form before purification begins.
- Analyse fractions individually rather than pooling by retention time.
- Weigh purity specifications against recovery when setting requirements.
Frequently Asked Questions
Why does higher purity cost more?
Because collecting a narrower centre cut raises purity while discarding product, so yield falls as the specification tightens.
Can I just load more material?
Only up to a point. Overloading broadens peaks and destroys resolution from closely related impurities.
When should I request a specific salt form?
Before purification, since the counterion is set during the final processing steps.
Why does tightening the specification from 95 to 98 percent cost more?
Because a narrower centre cut is collected, discarding material that sits under the shoulders of the peak. Yield falls as purity rises.
Related Reading
- peptide cyclisation methods
- peptide synthesis scale-up
- native chemical ligation
- peptide metal chelation
- evaluating peptide research
References & Further Reading
- Denton E et al. Tips and Tricks in Reversed-Phase Flash Chromatography for Peptide Purification. Methods Mol Biol. 2025. PubMed 40531458
- Fang YM et al. Review on biomimetic affinity chromatography with short peptide ligands and its application to protein purification. J Chromatogr A. 2018. PubMed 30097342
- Li P et al. Large-scale purification of a deprotected macrocyclic peptide by supercritical fluid chromatography (SFC) integrated with liquid chromatography in discovery chemistry. J Chromatogr A. 2024. PubMed 38972253
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- Peptide research collection at Nature
This article summarises published research practice for laboratory professionals. It is not a guide to human use, and no claim of therapeutic benefit is made or implied.
Reviewed by Dr. Elena Marchetti, Peptide Chemistry & Analytical Characterization.